Showing 101 - 120 results of 1,775 for search '"Therapy"', query time: 0.08s Refine Results
  1. 101
  2. 102

    Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? by Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti

    Published 2024-06-01
    “…Treatment guidelines highlight the need for effective control of inflammation and early escalation to advanced therapies to avoid long-term complications. Consequently, a large proportion of patients with IBD receive advanced therapies for a long time. …”
    Get full text
    Article
  3. 103

    Stimulus-activated ribonuclease targeting chimeras for tumor microenvironment activated cancer therapy by Yuqi Zhang, Jinfeng Zhu, Ling Qiu, Zhengzhong Lv, Zhongsheng Zhao, Xingxiang Ren, Yirui Guo, Yan Chen, Miao Li, Yurong Fan, Zhixin Han, Yiming Feng, Haibin Shi

    Published 2025-02-01
    “…Abstract RNA degradation using ribonuclease targeting chimeras (RiboTACs) is a promising approach for cancer therapy. However, potential off-target degradation is a serious issue. …”
    Get full text
    Article
  4. 104

    Asymptomatic Barrett’s Oesophagus-Complicated Gastroesophageal Reflux Disease at Ineffective Antisecretory Therapy by E. V. Barkalova, S. S. Pirogov, D. N. Andreev, M. A. Ovsepyan, I. V. Maev, A. D. Kaprin

    Published 2021-06-01
    “…A clinical description of gastroesophageal reflux disease (GERD) complicated by Barrett’s oesophagus (BO) at inadequate antisecretory therapy and the assessment of functional tests in control of conservative treatment.Key points. …”
    Get full text
    Article
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    Requiring durations of therapy at the time of antibiotic order entry reduces antibiotic use by Megan R. Wright, Jessica Gillon, Sophie E. Katz, Ritu Banerjee

    Published 2025-01-01
    “…The impact of required durations of therapy for antibiotic orders at the time of order entry has not been reported. …”
    Get full text
    Article
  10. 110
  11. 111
  12. 112

    The Effects of Catheter Ablation Therapy on Medication Use and Expenditures in Patients with Atrial Fibrillation by Matthew R. Reynolds, Guy David, Candace Gunnarsson, Jamie L. March, Steven C. Hao

    Published 2014-10-01
    “…Catheter ablation has been hypothesized to reduce the need for continued medical therapy for patients with AF, but there are few empirical data which demonstrate this. …”
    Get full text
    Article
  13. 113
  14. 114

    Dosimetry of automatic non-coplanar volumetric-modulated arc therapy for nasopharyngeal carcinoma by Kaiqiang Chen, Jihong Chen, Yanming Cheng, Danni Hong, Cairong Hu, Penggang Bai, Jinyong Lin, Yang Yang, Xiuchun Zhang

    Published 2025-02-01
    “…Methods: A retrospective analysis was conducted on 20 patients with initially diagnosed NPC who had received TomoTherapy (TOMO) treatment. Treatment plans were redesigned using HA technology on the Eclipse planning system. …”
    Get full text
    Article
  15. 115
  16. 116
  17. 117
  18. 118

    Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

    Published 2014-08-01
    “…To discuss options of telaprevir application and risk of adverse events at triple antiviral therapy (AVT) in patients with the 1-st genotype of chronic hepatitis C and compensated liver cirrhosis (LC), and options of pharmacological treatment of hematological complications by original clinical case example.Key points. …”
    Get full text
    Article
  19. 119

    Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss by Bing Wang, Wen Zhang, Jin Zhang, Qimei Yang, Bing Han, Hui Liu, Ziyu Zhao

    Published 2025-02-01
    “…Patients extending DF therapy to the 14th day showed a substantial improvement in the overall efficacy rate, from 50.98 to 82.35%. …”
    Get full text
    Article
  20. 120